Neuroendocrine and neurochemical effects of acute ibogaine administration: A time course evaluation

被引:18
作者
Ali, SF
Newport, GD
Slikker, W
Rothman, RB
Baumann, MH
机构
[1] NIDA,ADDICT RES CTR,CLIN PSYCHOPHARMACOL SECT,NIH,IRP,BALTIMORE,MD 21224
[2] US FDA,NATL CTR TOXICOL RES,NEUROCHEM LAB,DIV NEUROTOXICOL,JEFFERSON,AR 72079
关键词
ibogaine; prolactin; corticosterone; dopamine; serotonin;
D O I
10.1016/0006-8993(96)00734-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Ibogaine (IBO) is an indole alkaloid that is reported to facilitate drug abstinence in substance abusers. Despite considerable investigation, the mechanism of IBO action in vivo and its suitability as a treatment for drug addiction remains unclear. The present study was designed to evaluate the time-course effects of acute IBO on neuroendocrine and neurochemical indices. Adult male rats were treated with i.p. saline or 50 mg/kg IBO and sacrificed 15: 30, 60, 120 min and 24 h later. Trunk blood was collected for hormone measures and brains were dissected for neurochemical analyses. IBO produced a rapid elevation in plasma prolactin that declined to control levels by 60 min. Corticosterone levels increased 15 min after drug administration, continued to increase for 120 min, but returned to control levels 24 h after dosing. IBO decreased dopamine (DA) concentrations in the striatum and frontal cortex at 30, 60 and 120 min after injection while DA metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were elevated over the same time period. 24 h after IBO, DOPAC concentrations in striatum and HVA levels in the frontal cortex were below control values. Serotonin (5-HT) and its metabolite 5-hydroxyindole acetic acid (5-HIAA) were decreased at 60 min after IBO administration only in the striatum. These data indicate that a single injection of IBO produces a spectrum of effects that includes: (I) elevation of plasma prolactin and corticosterone, (2) short- and long-term effects on DA neurotransmission, and (3) modest, transient effects of 5-HT neurotransmission. The effects of IBO reported herein may have relevance to the anti-addictive properties of this drug, and this proposal warrants further investigation.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 36 条
[11]  
HOUGH LB, 1996, LIFE SCI, V58, pPL118
[12]  
IYENGAR S, 1986, J PHARMACOL EXP THER, V238, P429
[13]  
JOHNSON KM, 1983, FED PROC, V42, P2579
[14]   OPIOID K-RECEPTORS AND THE SECRETION OF PROLACTIN (PRL) AND GROWTH-HORMONE (GH) IN THE RAT .1. EFFECTS OF OPIOID K-RECEPTOR AGONISTS BREMAZOCINE AND U-50,488 ON SECRETION OF PRL AND GH - COMPARISON WITH MORPHINE [J].
KRULICH, L ;
KOENIG, JI ;
CONWAY, S ;
MCCANN, SM ;
MAYFIELD, MA .
NEUROENDOCRINOLOGY, 1986, 42 (01) :75-81
[15]   IBOGAINE POSSESSES A SELECTIVE AFFINITY FOR SIGMA(2) RECEPTORS [J].
MACH, RH ;
SMITH, CR ;
CHILDERS, SR .
LIFE SCIENCES, 1995, 57 (04) :PL57-PL62
[16]   ACUTE AND PROLONGED EFFECTS OF IBOGAINE ON BRAIN DOPAMINE METABOLISM AND MORPHINE-INDUCED LOCOMOTOR-ACTIVITY IN RATS [J].
MAISONNEUVE, IM ;
ROSSMAN, KL ;
KELLER, RW ;
GLICK, SD .
BRAIN RESEARCH, 1992, 575 (01) :69-73
[17]   INTERACTIONS BETWEEN IBOGAINE, A POTENTIAL ANTI-ADDICTIVE AGENT, AND MORPHINE - AN INVIVO MICRODIALYSIS STUDY [J].
MAISONNEUVE, IM ;
KELLER, RW ;
GLICK, SD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 199 (01) :35-42
[18]   PROPERTIES OF IBOGAINE AND ITS PRINCIPAL METABOLITE (12-HYDROXYIBOGAMINE) AT THE MK-801 BINDING-SITE OF THE NMDA RECEPTOR COMPLEX [J].
MASH, DC ;
STALEY, JK ;
PABLO, JP ;
HOLOHEAN, AM ;
HACKMAN, JC ;
DAVIDOFF, RA .
NEUROSCIENCE LETTERS, 1995, 192 (01) :53-56
[19]   IDENTIFICATION OF A PRIMARY METABOLITE OF IBOGAINE THAT TARGETS SEROTONIN TRANSPORTERS AND ELEVATES SEROTONIN [J].
MASH, DC ;
STALEY, JK ;
BAUMANN, MH ;
ROTHMAN, RB ;
HEARN, WL .
LIFE SCIENCES, 1995, 57 (03) :PL45-PL50
[20]   IBOGAINE INDUCES GLIAL ACTIVATION IN PARASAGITTAL ZONES OF THE CEREBELLUM [J].
OHEARN, E ;
LONG, DB ;
MOLLIVER, ME .
NEUROREPORT, 1993, 4 (03) :299-302